JPS62180269A - Enzyme immunological measuring method for free thyroxine - Google Patents
Enzyme immunological measuring method for free thyroxineInfo
- Publication number
- JPS62180269A JPS62180269A JP2342186A JP2342186A JPS62180269A JP S62180269 A JPS62180269 A JP S62180269A JP 2342186 A JP2342186 A JP 2342186A JP 2342186 A JP2342186 A JP 2342186A JP S62180269 A JPS62180269 A JP S62180269A
- Authority
- JP
- Japan
- Prior art keywords
- serum
- god
- thyroxine
- enzyme
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 17
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title claims abstract description 17
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 title claims abstract description 7
- 229940034208 thyroxine Drugs 0.000 title claims abstract description 7
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 title claims abstract description 7
- 230000001900 immune effect Effects 0.000 title abstract 2
- 229940088598 enzyme Drugs 0.000 claims abstract description 17
- 210000002966 serum Anatomy 0.000 claims abstract description 12
- 239000004366 Glucose oxidase Substances 0.000 claims abstract description 5
- 229940116332 glucose oxidase Drugs 0.000 claims description 4
- 108010015776 Glucose oxidase Proteins 0.000 claims description 3
- 235000019420 glucose oxidase Nutrition 0.000 claims description 3
- 238000002372 labelling Methods 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 abstract description 9
- 238000005259 measurement Methods 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 7
- 239000000427 antigen Substances 0.000 abstract description 6
- 102000036639 antigens Human genes 0.000 abstract description 6
- 108091007433 antigens Proteins 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 5
- 239000007790 solid phase Substances 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 238000010532 solid phase synthesis reaction Methods 0.000 abstract description 3
- 238000011088 calibration curve Methods 0.000 abstract description 2
- 238000006911 enzymatic reaction Methods 0.000 abstract description 2
- 102000006395 Globulins Human genes 0.000 abstract 1
- 108010044091 Globulins Proteins 0.000 abstract 1
- 102000007562 Serum Albumin Human genes 0.000 abstract 1
- 108010071390 Serum Albumin Proteins 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000003018 immunoassay Methods 0.000 description 7
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000011324 bead Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000006016 thyroid dysfunction Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920006130 high-performance polyamide Polymers 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000007982 barbital buffer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102220475870 Keratin, type I cytoskeletal 10_H13A_mutation Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 240000001970 Raphanus sativus var. sativus Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- BDKZHNJTLHOSDW-UHFFFAOYSA-N [Na].CC(O)=O Chemical compound [Na].CC(O)=O BDKZHNJTLHOSDW-UHFFFAOYSA-N 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- MLBBKTFJGPTWFM-ZOWNYOTGSA-N methyl (2s)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate;hydrochloride Chemical compound Cl.IC1=CC(C[C@H](N)C(=O)OC)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 MLBBKTFJGPTWFM-ZOWNYOTGSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 238000006395 oxidase reaction Methods 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、血清中の遊離型サイロキシン(以下FT4と
略す)を酵素免疫法によって定縫する新しい測定法に関
する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a new method for measuring free thyroxine (hereinafter abbreviated as FT4) in serum using an enzyme immunoassay.
血・m中のFT4を酵素免疫法によって定なする方法と
しては、β−D−ガラクトシダーゼ(以下β−Gatと
略す)を標ia酵素として使用する測定法(C1ini
cal Chemistr730 16112(198
4)、同誌 31 750 (1985))、ホース・
ラディッシュ・ペルオキシダーゼ(以下HRP ト略ス
)ヲ4i1m−t7−、”s%B r @I←fi 2
8 666(1982”)1が知られていた。As a method for determining FT4 in blood/m by enzyme immunoassay, there is a measurement method (C1ini
cal Chemistry730 16112 (198
4), same magazine 31 750 (1985)), Hose
Radish peroxidase (hereinafter referred to as HRP) wo4i1m-t7-,"s%Br @I←fi 2
8 666 (1982”) 1 was known.
FT4の測定は、新生児甲状腺機能不全、産後甲状腺機
能障害などの種々の甲状腺の機能に関する検査に有効で
あるが、サイロキシン結合グロブリン(以下TBGと略
す)および血清アルブミン(以下HIIIAと略す)な
どの血液中の蛋白質による影響が強く、そのため酵素免
疫法によって正確な測定値を得ることが内諾であった。Measurement of FT4 is effective for testing various thyroid functions such as neonatal thyroid dysfunction and postpartum thyroid dysfunction, but it is also effective for testing various thyroid functions such as neonatal thyroid dysfunction and postpartum thyroid dysfunction. It was strongly influenced by the proteins inside, and therefore it was necessary to obtain accurate measurements using enzyme immunoassay.
最近、サイロキシン(以下T4と略す)とβ−Gatと
の結合体(Ccnj uga te )がTBGおよび
H8Aなどの影響を受けることが少いことが見出され、
前記の如くβ−Gatを標識酵素としだ測定法が提案さ
れた。しかしながら、より一層TBG、 H13Aなど
の影#を受けないT4−酵素結合体を得るための標識酵
素の開発が望まれていた。Recently, it has been discovered that the conjugate of thyroxine (hereinafter abbreviated as T4) and β-Gat (Ccnjugate) is less affected by TBG and H8A.
As mentioned above, a measurement method using β-Gat as a labeled enzyme was proposed. However, there has been a desire to develop a labeled enzyme to obtain a T4-enzyme conjugate that is even less affected by TBG, H13A, and the like.
本発明者は長年に亘り酵素免疫測定法の開発研究に携り
、本研究に関しても鋭意研究を重ねていたところ、D−
グルコースオキシダーゼ(以下GODと略す)を標識酵
素として使用すると、TBGおよびH8Aのかなりの濃
度範囲まで、それらの影響を受けずに測定しうろことを
見い出して本発明を完成した。The present inventor has been involved in the development and research of enzyme immunoassay methods for many years, and as he was conducting intensive research regarding this research, he discovered that D-
The present invention has been completed by discovering that when glucose oxidase (hereinafter abbreviated as GOD) is used as a labeling enzyme, it is possible to measure a considerable concentration range of TBG and H8A without being influenced by them.
本発明に係る酵素免疫測定法において、反応手法自体お
よび酵素活性の測定自体は、いずれも種々の公知の手段
〔例えば、石川・筒金・宮井共編:酵素免疫測定法(第
2版) (1982年株式会社医学書院発行)参照〕を
採用しうるものであるが、酵素反応としては簡単に且つ
比較的妨害な〈実施しうるものとして、二抗体固相法が
好ましい。これによれば、血清中の遊離T4は測定試料
血清および標識抗原であるT4とGODとの結合体(以
下T4−GODと略す)を第1抗体と接触反応させ、次
いで固相化第2抗体と接触反応させ、固相上の酵素活性
を測定し、予めT4標準試料を用いて作成した検母線と
対比させて定量される。酵素活性の測定法としては、通
常は螢光法が高感度である。例えば、グルコース−グル
コースオキシダーゼの反応により生じた過i化水素を、
HRPとp−ヒドロキシフェニルプロピオン酸との系に
のせ、励起波長320nm。In the enzyme immunoassay according to the present invention, the reaction method itself and the enzyme activity measurement itself can be carried out using various known methods [for example, Ishikawa, Tsutsugane, and Miyai, co-eds.: Enzyme immunoassay (2nd edition) (1982) However, as an enzymatic reaction, the two-antibody solid-phase method is preferred as it is simple and relatively unhindered (as a practicable method). According to this, free T4 in serum is obtained by contacting and reacting the measurement sample serum and a conjugate of T4 and GOD (hereinafter abbreviated as T4-GOD), which is a labeled antigen, with a first antibody, and then using a second antibody immobilized on a solid phase. The enzyme activity on the solid phase is measured and quantified by comparing it with a standard line prepared in advance using a T4 standard sample. Fluorescence is usually a highly sensitive method for measuring enzyme activity. For example, hydrogen peride produced by the glucose-glucose oxidase reaction,
Placed on a system of HRP and p-hydroxyphenylpropionic acid, excitation wavelength 320 nm.
螢光波長405nmで螢光強度を測定する。The fluorescence intensity is measured at a fluorescence wavelength of 405 nm.
次に二抗体固相法による実施例および参考例をあげて、
本発明の方法を更に具体的に説明するが、本発明はこれ
によって限定されるものではない。Next, we will give examples and reference examples using the two-antibody solid phase method.
The method of the present invention will be explained in more detail, but the present invention is not limited thereto.
参考例1 緩衝液の調製
1、 0.2 M (pH8,6)バルビタール緩衝液
(試験用)
パルビタールナトリウム12.3708Fを500ゴに
近い址の水に溶かし、12N塩酸でpH8,6とし、ウ
シ血清アルブミンα5fを加えた汲水を加えて総量50
0プとする。Reference Example 1 Preparation of buffer solution 1, 0.2 M (pH 8.6) barbital buffer solution (for testing) Parbital sodium 12.3708F was dissolved in approximately 500 g of water, adjusted to pH 8.6 with 12N hydrochloric acid, Add the pumped water containing bovine serum albumin α5F to a total volume of 50
Set it to 0p.
2、101M(p)17.0)リン酸(食@を含む)緩
衝液(FIRP希釈用)
リン酸2水素カリウム1.3608?および食塩9fを
水に溶かし総量1tとする(A)。2, 101M (p) 17.0) Phosphate (contains food) buffer (for diluting FIRP) Potassium dihydrogen phosphate 1.3608? Dissolve 9 f of common salt in water to make a total amount of 1 t (A).
リン酸水素2カリウム3.806Fおよび食塩111f
を水に溶かして総t2tとする(B)。Dipotassium hydrogen phosphate 3.806F and salt 111F
Dissolve in water to obtain total t2t (B).
上記AとBとを合しpH7,0に調整する。Combine the above A and B and adjust the pH to 7.0.
λ α25M(1)H5,O)酢酸緩衝液(グルコース
希釈用)
酢酸ナトリウム17.01fを1水5aortttに溶
かす。λ α25M(1)H5,O) Acetate buffer (for diluting glucose) Dissolve 17.01f of sodium acetate in 15a orttt of water.
酢酸14.31r/Llを水1jlC溶かし、上記酢酸
“ナトリウム溶液と合わせ、p)i s、 oにf3整
する。Dissolve 14.31r/Ll of acetic acid in 1jlC of water, combine with the above sodium acetic acid solution, and adjust p)is, o to f3.
参考例2 各種溶液の調製
1、 HRP溶液
HRP (261Tl/my) (TOYOBO製)1
0彎をとり、前記リン酸緩衝液6.525m1K溶かし
く40QU/+ILl)、用時20倍に希釈(20−”
/yd)して使用する。Reference example 2 Preparation of various solutions 1, HRP solution HRP (261Tl/my) (manufactured by TOYOBO) 1
Remove 0 curvature, dissolve 6.525ml of the above phosphate buffer (40QU/+ILl), and dilute 20 times before use (20-"
/yd) and use it.
2 α5%3−(p−ヒドロキシフェニル)フロピオン
酸(以下HPPAと略す)溶液HPPA0.5 fを水
IQOmlに溶かす。2 α5% 3-(p-hydroxyphenyl)propionic acid (hereinafter abbreviated as HPPA) solution Dissolve 0.5 f of HPPA in IQOml of water.
3.0.5Mグルコース溶液
グルコース22.52Fを前記酢酸緩衝4ffi250
Mに溶かす。3.0.5M glucose solution Glucose 22.52F was added to the acetate buffer 4ffi250
Dissolve in M.
本 アジ化ナトリウム溶液 アジ化ナトリウム0.1tを水100dに溶かす。Book sodium azide solution Dissolve 0.1 t of sodium azide in 100 d of water.
参考例3T4−GODの調製
101nl用ナス型コルベンにサイロキシンメチルエス
テル塩酸塩3rn9を95%ジメチルホルムアミド1M
に溶解し、グルコースオキシダーゼ(105v/m9、
TOYOBO製)109を含む水溶液1dを加え、攪拌
し、1チグルタルアルデヒド溶液α21rttlを滴下
しながら加え、室温で2時間反応する。得られた結合物
は0.05MIJン酸緩衝i (pHa、 O)に1夜
4℃で透析し、Tyopal HW55 (I X 5
(lcIn)カラムクロマトグラフィーにより精製し
た。Reference Example 3 Preparation of T4-GOD Thyroxine methyl ester hydrochloride 3rn9 was added to 95% dimethylformamide 1M in a 101nl eggplant-shaped colben.
Glucose oxidase (105v/m9,
1d of an aqueous solution containing 109 (manufactured by TOYOBO) was added, stirred, and added dropwise with 1tiglutaraldehyde solution α21rttl, and reacted at room temperature for 2 hours. The resulting conjugate was dialyzed against 0.05 MIJ acid buffer i (pHa, O) overnight at 4°C and dialyzed in Tyopal HW55 (I x 5
(lcIn) column chromatography.
参考例4 抗T4血清の調製
T−ヘミゲルタレ−)−BSAを抗原として家兎を免疫
し、抗血清を調製した(クリニカル・ケミストリー 3
1巻430頁 1985年)。Reference Example 4 Preparation of anti-T4 serum A rabbit was immunized with T-hemigeltare-BSA as an antigen, and an antiserum was prepared (Clinical Chemistry 3)
Volume 1, page 430, 1985).
参考例5 固定化第二抗体の調製
精製された家兎のIGを結合させたセファ口−スゲルを
使用したアフイニテイクロマトグラフイーによって′n
!製した抗家兎工gG山羊Ig()を0.55%リン酸
ナトリウム溶液(1%アジ化ナトリウム含有、pH7,
4)に溶かした22μm〜溶液に、ポリアセタールビー
ズ(フジレビオM)1個を4℃で1夜浸漬し、次いで0
.3%BSA溶液でポストコーティングしたビーズを用
いる。Reference Example 5 Preparation of immobilized second antibody 'n by affinity chromatography using Sephas gel bound with purified rabbit IG.
! The prepared anti-rabbit IgG goat Ig () was added to a 0.55% sodium phosphate solution (containing 1% sodium azide, pH 7,
One polyacetal bead (Fujirebio M) was immersed overnight at 4°C in a solution of 22 μm or more dissolved in 4), and then
.. Beads post-coated with 3% BSA solution are used.
参考例6 FT4標準試料ディスクおよび検体試料デ
ィスクの調製
常法(クリニカル・ケミストリー 24巻2号362頁
1978年)に従って調製したりガントフリーの血清に
、生理食塩水およびリガンドフリー血清で洗った血球を
、ヘマトクリツ)50チとして混合する。その4 m/
K T4 (遊離酸)の希釈液(400〜6.25μ
f/ytlの各捌濃度)20μtを加え、よく混合する
。これら各種濃度の液を夫々パスツールパイベラトラ用
いて新生児マススクリーニング用r紙に1滴(zTμt
)ずつたらし、室温で一夜乾燥して、FT4標準試料デ
ィスクとした。T4(遊離酸)の希釈液の代りに検体試
料血清1滴を前記と同様の2紙にたらし、乾燥したもの
が検体試料ディスクとした。Reference Example 6 Preparation of FT4 standard sample disk and specimen sample disk Blood cells prepared according to the conventional method (Clinical Chemistry Vol. 24, No. 2, p. 362, 1978) or Gant-free serum washed with physiological saline and ligand-free serum. , hematocrit). Part 4 m/
K T4 (free acid) diluted solution (400-6.25μ
Add 20 μt of each sample concentration of f/ytl and mix well. One drop of each of these solutions at various concentrations (zTμt
) and dried at room temperature overnight to obtain an FT4 standard sample disk. Instead of the diluted solution of T4 (free acid), one drop of specimen sample serum was placed on the same two papers as above, and the dried product was used as a specimen sample disk.
実施例I FT4の酵素免疫測定法
抗T4血清(参考例4、X400000) 100μt
1乾燥試料デイスク(参考例6、T4標準試料ディスク
、3罷φ)1枚、T4−GODC参考例3、X250G
)100μt、0.12Mバルビタール緩衝液〔参考例
1−1)250μtおよび固定化第二抗体ビーズ(参考
例5、)1個を混合し4℃で1夜放置した。Example I Enzyme immunoassay for FT4 Anti-T4 serum (Reference example 4, X400000) 100μt
1 Dry sample disk (Reference example 6, T4 standard sample disk, 3 lines φ) 1 piece, T4-GODC Reference example 3, X250G
) 100 μt, 0.12 M barbital buffer [Reference Example 1-1) 250 μt and one immobilized second antibody bead (Reference Example 5) were mixed and left at 4° C. overnight.
r取したビーズを生理食塩水1,5フで3度洗った後、
0.5Mグルコース溶液(#前例2−3)SOQμt、
HRP溶液(参考例2−1)50μlおよび0.5%
HPPA溶液(参考例2−2)50μtと共に37℃で
1時間放置する。反応溶液に2N水酸化ナトリウム水溶
液とアシ化ナトリウム溶液(参考例2−4)との1:1
混液IQQμtを繞加し、日立螢光光度計を使用し32
0nm(励起波長)と405nm(螢光波長)の螢光強
度を測定し定量した。第1図にその結果(FT4の検を
線)を示した。横軸はFT4の量(nf/d4 )であ
り縦軸は相対強度を示す。BoはFT4のない場合の強
度でありBはFT4を添加した場合の強度である。After washing the collected beads three times with 1.5 liters of physiological saline,
0.5M glucose solution (#Example 2-3) SOQμt,
HRP solution (Reference Example 2-1) 50 μl and 0.5%
It is left at 37° C. for 1 hour with 50 μt of HPPA solution (Reference Example 2-2). The reaction solution was a 1:1 mixture of 2N aqueous sodium hydroxide solution and sodium acyde solution (Reference Example 2-4).
Add the mixed solution IQQμt and use a Hitachi fluorometer to measure 32
The fluorescence intensities at 0 nm (excitation wavelength) and 405 nm (fluorescence wavelength) were measured and quantified. The results are shown in Figure 1 (the line represents the test for FT4). The horizontal axis represents the amount of FT4 (nf/d4), and the vertical axis represents relative intensity. Bo is the strength without FT4, and B is the strength when FT4 is added.
実施例2 TBGの影響
実施例1においてT4標準試料濃度を0.661’/d
zのディスクを使用し1反応系内にTBGを添加して、
実施例1と同様に反応を行なった結果を第2図に示した
(図中 ・ 印)。比較として I−T を使用し
て行なったFT4の測定値に対するTBGの影響をみた
ものを同図上に示した(図中 ム 印)(−T4を使用
した測定はアマー社アマレックスFT4キットによった
)。Example 2 Effect of TBG In Example 1, the T4 standard sample concentration was set to 0.661'/d.
Add TBG to one reaction system using Z disk,
The reaction was carried out in the same manner as in Example 1, and the results are shown in FIG. 2 (indicated by * in the figure). For comparison, the influence of TBG on the measured values of FT4 using IT is shown on the same figure (marked with a square in the figure). ).
図から明らかなように、 I−T4を使用した測定法
では、TBGの濃度の上昇によって急激にFT4の測定
値が影響されるが、本発明方法における測定値の受ける
影響は著しく弱い。As is clear from the figure, in the measurement method using I-T4, the FT4 measurement value is rapidly affected by an increase in the TBG concentration, but the measurement value in the method of the present invention is significantly less affected.
実施例3 ISAの影響
実施例2においてTBGの代りにISAを使用して同様
に反応を行なった。結果を第3図に示した。図中 ・
は本発明方法による測定結果に@ ” 12
5
よるものであり、 ム は −T4を使用した測定結
果によるものである。Example 3 Effect of ISA The reaction was carried out in the same manner as in Example 2 using ISA instead of TBG. The results are shown in Figure 3. In the diagram ・
is the measurement result by the method of the present invention @ ” 12
5, and MU is based on the measurement results using -T4.
図から明らかなように、本発明の方法はHIAについて
は殆んど影響を受けない。As is clear from the figure, the method of the present invention is almost insensitive to HIA.
標識抗原であるT4−GODは、TBG″? ISAに
対する親和性が極めて低く、従ってその測定値は血中の
TBG −? ISAにより影響を受けることが少い。T4-GOD, which is a labeled antigen, has extremely low affinity for TBG''? ISA, and therefore its measured value is rarely affected by TBG''? ISA in the blood.
また感度が非常に高いので、全血2.7μを程度で充分
FT4の測定を行なうことができる。本発明方法の検出
限界はIIL05 nf / 61 (1,35ft/
チューブ)である。Furthermore, since the sensitivity is very high, FT4 can be measured with just 2.7μ of whole blood. The detection limit of the method of the present invention is IIL05 nf/61 (1,35 ft/
tube).
第1図はT4の検量線であり、横軸は試料で4の量、縦
軸はT4−GODによる螢光強度の相対値を示す。第2
図はTおよびT−GODと抗T4抗体との反応に対する
TBGの影響を示したもので、横軸はTBGの添加皺、
縦軸はT4−CODによる螢光強度の相対値を示す。第
3図はT4およびT4−GODと抗T4抗体との反応に
対するISAの影響を示したもので、横軸はISAの添
加盪、縦軸はT−GODによる螢光強度の相対値を示す
。第1図〜第3図の縦−軸におけるB は横軸の添加物
のない状態の強度であり、Bは添加物の存在した状態で
の強度である。FIG. 1 is a calibration curve for T4, where the horizontal axis shows the amount of 4 in the sample and the vertical axis shows the relative value of the fluorescence intensity due to T4-GOD. Second
The figure shows the influence of TBG on the reaction between T and T-GOD and anti-T4 antibody.
The vertical axis indicates the relative value of fluorescence intensity by T4-COD. FIG. 3 shows the influence of ISA on the reaction between T4 and T4-GOD and anti-T4 antibody, where the horizontal axis shows the addition of ISA and the vertical axis shows the relative value of the fluorescence intensity due to T-GOD. B on the vertical axis of FIGS. 1 to 3 is the strength without the additive on the horizontal axis, and B is the strength in the presence of the additive.
Claims (1)
を特徴とする血清中の遊離型サイロキシンの測定法。A method for measuring free thyroxine in serum, characterized in that glucose oxidase is used as a labeling enzyme.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61023421A JPH06105252B2 (en) | 1986-02-05 | 1986-02-05 | Enzyme-linked immunosorbent assay for free thyroxine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61023421A JPH06105252B2 (en) | 1986-02-05 | 1986-02-05 | Enzyme-linked immunosorbent assay for free thyroxine |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62180269A true JPS62180269A (en) | 1987-08-07 |
JPH06105252B2 JPH06105252B2 (en) | 1994-12-21 |
Family
ID=12110037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61023421A Expired - Fee Related JPH06105252B2 (en) | 1986-02-05 | 1986-02-05 | Enzyme-linked immunosorbent assay for free thyroxine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH06105252B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105137095A (en) * | 2015-08-21 | 2015-12-09 | 孙丽华 | Immunoassay kit for free thyroxine |
CN105372428A (en) * | 2015-12-08 | 2016-03-02 | 孙丽华 | Quantitative detection kit of carbohydrate chain antigen 125 |
CN113495157A (en) * | 2020-03-20 | 2021-10-12 | 郑州达诺生物技术有限公司 | Enzyme conjugate diluent, total thyroxine quantitative detection kit and use method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52108017A (en) * | 1976-03-04 | 1977-09-10 | Eiken Chemical | Measurement for thyroid gland hormon |
JPS57132060A (en) * | 1980-12-23 | 1982-08-16 | Boehringer Mannheim Gmbh | Peculiarly bonding protein and method of measuring one component in reaction of material able to be bonded thereto |
JPS59193357A (en) * | 1983-04-18 | 1984-11-01 | Sankyo Co Ltd | Measuring method of enzyme immunity |
-
1986
- 1986-02-05 JP JP61023421A patent/JPH06105252B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52108017A (en) * | 1976-03-04 | 1977-09-10 | Eiken Chemical | Measurement for thyroid gland hormon |
JPS57132060A (en) * | 1980-12-23 | 1982-08-16 | Boehringer Mannheim Gmbh | Peculiarly bonding protein and method of measuring one component in reaction of material able to be bonded thereto |
JPS59193357A (en) * | 1983-04-18 | 1984-11-01 | Sankyo Co Ltd | Measuring method of enzyme immunity |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105137095A (en) * | 2015-08-21 | 2015-12-09 | 孙丽华 | Immunoassay kit for free thyroxine |
CN105137095B (en) * | 2015-08-21 | 2016-05-04 | 陈立国 | The immunoassay kits of free thyroxine |
CN105372428A (en) * | 2015-12-08 | 2016-03-02 | 孙丽华 | Quantitative detection kit of carbohydrate chain antigen 125 |
CN105372428B (en) * | 2015-12-08 | 2016-08-24 | 陈立国 | The immue quantitative detection reagent box of CA125 |
CN113495157A (en) * | 2020-03-20 | 2021-10-12 | 郑州达诺生物技术有限公司 | Enzyme conjugate diluent, total thyroxine quantitative detection kit and use method thereof |
Also Published As
Publication number | Publication date |
---|---|
JPH06105252B2 (en) | 1994-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4578361A (en) | Creatinine antibody | |
JPS63500672A (en) | Colorimetric assay for substances that can bind | |
JPS61107158A (en) | Testing method | |
JP2000508075A (en) | Luminescence-specific binding assay | |
Maiolini et al. | A sandwich method of enzyme-immunoassay. II. Quantification of rheumatoid factor | |
JPH01248061A (en) | Washing liquid, test kit and measurement of immunological ligand | |
EP0096463B1 (en) | Immunoglobulin half-molecules and process for producing hybrid antibodies | |
JP2603422B2 (en) | Analyte measuring method and measuring means | |
JP2517696B2 (en) | Pulmonary Disease Marker Protein Assay | |
JPH07325083A (en) | Method for measuring ratio of specific sugar chain of glycoprotein | |
JPS62180269A (en) | Enzyme immunological measuring method for free thyroxine | |
US4786591A (en) | Process for determining the binding capacity of thyroxin-binding globulin | |
JPS61186855A (en) | Method of measuring combining capacity of globulin forming thyroxine | |
JP2543630B2 (en) | Measuring method of glycation ratio of specific protein | |
JPS61243363A (en) | Highly sensitive assay of crp | |
CA1193192A (en) | Method of determinination of human urine kallikrein and kit for the same | |
Wood et al. | [30] Luminescence immunoassays for haptens and proteins | |
JP2534067B2 (en) | Quantitative method for C-reactive protein | |
JPS6140066B2 (en) | ||
JPH1123574A (en) | Method combining enzyme with physiological active substance | |
JPH0236353A (en) | Immunoassay | |
JPS6113183B2 (en) | ||
JPH0751079B2 (en) | Uric acid diagnostic assay using microperoxidase | |
JPS6385358A (en) | Enzymatic immunoassay of blood release type triiode thyronine | |
JP2520465B2 (en) | Multi-labeled antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |